CATEGORY
Comparator Drug Sourcing
Beroe LiVE.Ai™
AI-powered self-service platform for all your sourcing decision needs across 1,600+ categories llike Comparator Drug Sourcing.
Market Data, Sourcing & Supplier Intelligence, and Price & Cost Benchmarking.
Category Alerts
European power prices further increases
August 16, 2022Drought in the Sichuan Province in China
August 17, 2022India postpones coal plant closure
August 18, 2022Become a Beroe LiVE.Ai™ Subscriber to receive proactive alerts on Comparator Drug Sourcing
Comparator Drug Sourcing Market Monitoring Dashboard
Understand the correlation between costs, margins, and prices impacting your category on a real time basis on Beroe LiVE.Ai™
Comparator Drug Sourcing Industry Benchmarks
Savings Achieved
(in %)
The average annual savings achieved in Comparator Drug Sourcing category is 8.10%
Payment Terms
(in days)
The industry average payment terms in Comparator Drug Sourcing category for the current quarter is 35.0 days
Compare your category performance against peers and industry benchmarks across 20+ parameters on Beroe LiVE.Ai™
Category Strategy and Flexibility
Engagement Model
Supply Assurance
Sourcing Process
Supplier Type
Pricing Model
Contract Length
SLAs/KPIs
Lead Time
Supplier Diversity
Targeted Savings
Risk Mitigation
Financial Risk
Sanctions
AMEs
Geopolitical Risk
Cost Optimization
Price per Unit Competitiveness
Specification Leanness
Minimum Order Quality
Payment Terms
Inventory Control
The World’s first Digital Market Analyst
Abi, the AI-powered digital assistant brings together data, insights, and intelligence for faster answers to sourcing questions
Comparator Drug Sourcing Suppliers

Find the right-fit comparator drug sourcing supplier for your specific business needs and filter by location, industry, category, revenue, certifications, and more on Beroe LiVE.Ai™.



Use the Comparator Drug Sourcing market, supplier and price information for category strategy creation and Quaterly Business Reviews (QRBs)
Comparator Drug Sourcing market frequently asked questions
The global comparator drug sourcing market attained a valuation of $0.96 Bn in 2020, and the figure is likely to multiply at 7-7.5 CAGR during 2020-2025.
As part of their market strategy, global comparator drug sourcing market players are focusing on sourcing comparators and clinical trials from emerging countries at better pricing. In addition, they are tapping into small markets by joining forces with distributors/logistics players who can deliver to different regions with fewer supply bases.
The COVID-19 pandemic has adversely affected the logistics of trial supplies, from the pre-clinical stage to data analysis. While the crisis has underscored the need for automation, industry growth has slumped by 5-10% due to a limited workforce.
Innovations in the trial supply chain via e-commerce platforms using artificial intelligence (AI) will enable delivery to multiple locations. Moreover, these platforms allow market players to connect with various distributors for a specific trial supply, including comparators, and examine the suitable distributor.
Equipping comparator sourcing with AI boosts the operational efficacy and slashes the trial cost by decreasing sourcing overages. Moving ahead, implementing blockchain in pharma supply chain financial service platforms improves visibility, efficiency, and financial operations.
Several global comparator drug sourcing market players are integrating interactive response technology (IRT) with an electronic data capture (EDC) to improve transparency in clinical operations and the flow of clinical supply. Moreover, fusing IRT with real-time tracking equipment enhances flexibility and makes it easy for medical professionals to monitor patients residing in remote areas.
Comparator Drug Sourcing market report transcript
The global market is expected to grow with a CAGR of 7-7.5 percent between 2020 and 2025
- 2020 market value stood up to $ 0.96 billion
- Emerging countries in Eastern Europe and Asia pacific have been evolving in providing comparators and clinical trialsupplies which can cater to the client needs across globe. Sourcing from emerging countries provide value for the productat better pricing
- At the same time global players are reaching small markets by expanding their network with distributors/logistics playerswho can deliver to regions with fewer supply base.
Impact of COVID-19 on Comparator Sourcing
While COVID-19 outbreak has greatly impacted trial supply value chain from pre-clinical until data analysis, one of the main reasons for huge impact is lack of demand forecast and feasibility planning. In the future, pharma companies can adopt collaborative approach for procurement of trial supplies and have a diversified supplier base
- Reliance on single global player is reducing owing to the pandemic and pharma is now looking for diversified local players as well to minimize logistic and supply disruptions
Digitization in procurement
- Innovations in the trial supply chain through innovative e-commerce platforms using artificial intelligence is revolutionizing this space where delivery to various sites is possible through these platforms
- These platforms also enable to connect with various suppliers for a particular trial supply including comparators and evaluate the right supplier
Import of API and logistics
- Given the virus outbreak, logistics of trial supplies has taken a big hit. India has restricted export of 26 active ingredients, which is about 10 percent of all drug exports from India.
Consolidated base for trial supplies
- There is a heavy reliance on the global suppliers for trial supplies, given that they have centralized inventory management and platform to manage workflow.
Market Trends
The COVID-19 pandemic has created the need for automation, but also has resulted in 5-10 percent dip in the industry. This may be due to industries working with limited workforce
Use of IRT/RTSM
- To improve efficiency in clinical trial processes, to save valuable resources, pharma is automating clinical trial supplies process including sourcing of comparators that includes adopting new technologies in packaging and labelling, printing, use of IRT and RTSM and integrating the solutions for efficient clinical operations. Industry is moving to Integrate IRT systems with EDC to enhance visibility in clinical operations and flow of clinical supply
- IRT provides access to patient data and on time delivery of drugs to the patient, which increases the efficiency of trial and reduces the cost to trial (reduces overages).
- Integrating IRT with real-time monitoring devices will increase the flexibility and make it easy for investigators to monitor patients in remote location.
- Suppliers are actively moving to adopt digital data collection from paper based process.
AI & Block Chain Technology
Applying AI to comparator sourcing will increase the operational efficiency and reduces the trial cost by reducing the overages of sourcing
- A clinical supply chain management company developed logistics software platform that uses EDC and IRT to actively monitor clinical supply consumption, patient timelines and supply kit expiration
- Block Chain is being implemented in pharma procurement supply chain financial services platform to improve efficiency, transparency, and financial operations
- In Africa, mass serialization and block chain tech(assigning an ID for a product and saving as an asset in the block chain) is being adapted to reduce counterfeit and illegal supply of drugs